Today, pharmacovigilance is a top priority of every pharmaceutical company in the globally diverse and evolving regulatory environment. With the increasing number of adverse drug reactions and the accelerated demand for personalized medicines, the pharmacovigilance (PV) function is growing exponentially and becoming more complex. Existing PV strategies are falling short of meeting the requirements of this increasingly dynamic landscape. Pharmaceutical companies are rethinking their PV operating models, and setting up more diligent and effective processes and robust technologies to transform their pharmacovigilance function.

Wipro is a global leader in providing pharmacovigilance solutions through its widely accepted digital transformation and delivery footprint in the US, EMEA, AFME, LATAM, and APAC regions. Our scalable and sustainable PV operating model brings value to organizations by optimizing human capital, and by enhancing product quality and patient safety.

Our solutions have registered one of the fastest growth curves in the recent past. We have dedicated centers of excellence focusing on:

• Medical Information Contact Center (MICC): Wipro’s MICC is a well-established unit, providing specialized services in managing medical inquiries, handling product quality complaints and adverse event management.
• Individual Case Safety Report (ICSR) Management: Wipro offers a cost-effective adverse event management system for post marketing and clinical trial cases for global regions.
• Signal and Risk Management: We provide companies with risk management and support services in preparation of communication plan, signal detection, validation, and prioritization and characterization.
• Literature Search: Wipro has extensive capability in performing literature search and analysis in various databases using a specialized search strategy that has been developed to identify relevant safety publications and, at the same time, minimize non-relevant publications.
• Qualified Person for Pharmacovigilance (QPPV) Services: Our QPPVs are highly qualified and experienced EU residents, supporting as Point of Contact for EMEA, AFME, LATAM & APAC regions along with National Competent Authorities on a 24/7 basis.
• Medical Writing: Our medical writing team has extensive industry experience in authoring, reviewing, and submission of high quality documents for regulatory submissions and scientific communications. Our services include authoring, review, finalization, publishing and submission of reports.

• 24x7 global medical information call center
• Over 1,000 global workforce experts
• In-house PV automation platform
• End-to-end pharmacovigilance solutions at a disruptive price point
• A Wipro core safety team supported by its Six Sigma Certified black belts, quality assurance experts/auditors and trainers
• PV automation solutions built using robotics, artificial intelligence, cognitive/machine learning over Wipro’s proprietary platforms such as HOLMES^TM, DDP, BASE)))^TM and analytics engines

Our next-generation PV system is a perfect blend of domain knowledge, operations, and technology – helping you achieve your proactive pharmacovigilance goals.

Connect with us to learn how we can take your pharmacovigilance activities to the next level and drive successful outcomes.